We here show that in breast carcinomas, LARP6 expression is strongly upregulated by EMT, and cells that have undergone EMT are more dependent on LARP6, suggesting that LARP6 inhibition could potentially be used as a therapeutic strategy to specifically inhibit ribosome biogenesis in EMT associated carcinomas. This evidence concerns the gene LARP6 and breast carcinoma.